Numerous studies demonstrate a global decrease in nicotinamide adenine dinucleotide (NAD+) with aging. This decline is associated with the development of several of the hallmarks of aging such as reduced mitophagy and neuroinflammation, processes thought to play a significant role in the progression of Alzheimer's disease (AD). Augmentation of NAD+ by oral administration of a precursor, nicotinamide riboside (NR), reduces senescence of affected cells, attenuates DNA damage and neuroinflammation in the transgenic APP/PS1 murine model of AD. Inflammation mediated by microglial cells plays an important role in progression of AD and other neurodegenerative diseases. The cytoplasmic DNA sensor, cyclic GMP-AMP synthase (cGAS) and downstream stimulator of interferon genes (STING), generates an interferon signature characteristic of senescence and inflammaging in the brain of AD mice. Elevated cGAS–STING observed in the AD mouse brains and human AD fibroblasts was normalized by NR. This intervention also increased mitophagy with improved cognition and behavior in the APP/PS1 mice. These studies suggest that modulation of the cGAS–STING pathway may benefit AD patients and possibly other disorders characterized by compromised mitophagy and excessive neuroinflammation.
Get full access to this article
View all access options for this article.
References
1.
MuirasML, MüllerM, SchächterF, BürkleA. Increased poly(ADP-ribose) polymerase activity in lymphoblastoid cell lines from centenarians. J Mol Med, 1998; 76:346–354.
2.
GrubeK, BürkleA. Poly(ADP-ribose) polymerase activity in mononuclear leukocytes of 13 mammalian species correlates with species-specific life span. Proc Natl Acad Sci U S A, 1992; 89:11759–11763.
3.
BonkowskiMS, SinclairDA. Slowing ageing by design: The rise of NAD(+) and sirtuin-activating compounds. Nat Rev Mol Cell Biol, 2016; 17:679–690.
4.
GuarenteL. Calorie restriction and sirtuins revisited. Genes Dev, 2013; 27:2072–2085.
MillsKF, YoshidaS, SteinLR, et al.Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab, 2016; 24:795–806.
7.
d'AvilaJC, SiqueiraLD, MazeraudA, et al.Age-related cognitive impairment is associated with long-term neuroinflammation and oxidative stress in a mouse model of episodic systemic inflammation. J Neuroinflammation, 2018; 15:28.
8.
LiQ, BarresBA. Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol, 2018; 18:225–242.
9.
OwnbyRL. Neuroinflammation and cognitive aging. Curr Psychiatry Rep, 2010; 12:39–45.
10.
WangW-Y, TanM-S, YuJ-T, TanL. Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease. Ann Transl Med, 2015; 3:136.
11.
HouY, WeiY, LautrupS, et al.NAD + supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS–STING. Proc Natl Acad Sci U S A, 2021; 118:e2011226118.
12.
TanM-S, YuJ-T, JiangT, ZhuX-C, TanL. The NLRP3 inflammasome in Alzheimer's disease. Mol Neurobiol, 2013; 48:875–882.
13.
HenekaMT, KummerMP, StutzA, et al.NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature, 2013; 493:674–678.
14.
IsingC, VenegasC, ZhangS, et al.NLRP3 inflammasome activation drives tau pathology. Nature, 2019; 575:669–673.
15.
HouY, LautrupS, CordonnierS, et al.NAD+ supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proc Natl Acad Sci U S A, 2018; 115:E1876–E1885.
WestAP, Khoury-HanoldW, StaronM, et al.Mitochondrial DNA stress primes the antiviral innate immune response. Nature, 2015; 520:553–557.
18.
McArthurK, WhiteheadLW, HeddlestonJM, et al.BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis. Science, 2018; 359:eaao6047.
19.
KranzuschPJ, LeeAS-Y, BergerJM, DoudnaJA. Structure of human cGAS reveals a conserved family of second-messenger enzymes in innate immunity. Cell Rep, 2013; 3:1362–1368.
20.
YuL, LiuP. Cytosolic DNA sensing by cGAS: Regulation, function, and human diseases. Signal Transduct Targeted Ther, 2021; 6:1–15.
21.
YohSM, SchneiderM, SeifriedJ, et al.PQBP1 is a proximal sensor of the cGAS-dependent innate response to HIV-1. Cell, 2015; 161:1293–1305.
22.
LiaoC-Y, LeiC-Q, ShuH-B. PCBP1 modulates the innate immune response by facilitating the binding of cGAS to DNA. Cell Mol Immunol, 2021; 18:2334–2343.
23.
AbeT, HarashimaA, XiaT, et al.STING recognition of cytoplasmic DNA instigates cellular defense. Mol Cell, 2013; 50:5–15.
24.
MagisAD, ManzoSG, RussoM, et al.DNA damage and genome instability by G-quadruplex ligands are mediated by R loops in human cancer cells. Proc Natl Acad Sci U S A, 2019; 116:816–825.
25.
CrossleyMP, BocekM, CimprichKA. R-loops as cellular regulators and genomic threats. Mol Cell, 2019; 73:398–411.
26.
SunL, WuJ, DuF, ChenX, ChenZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type-I interferon pathway. Science, 2013; 339:786–791.
27.
WuJ, SunL, ChenX, et al.Cyclic-GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science, 2013; 339:826–830.
28.
HärtlovaA, ErttmannSF, RaffiFA, et al.DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity. Immunity, 2015; 42:332–343.
29.
YangH, WangH, RenJ, ChenQ, ChenZJ. cGAS is essential for cellular senescence. Proc Natl Acad Sci U S A, 2017; 114:E4612–E4620.
30.
LautrupS, SinclairDA, MattsonMP, FangEF. NAD+ in brain aging and neurodegenerative disorders. Cell Metab, 2019; 30:630–655.
31.
TrammellSAJ, SchmidtMS, WeidemannBJ, et al.Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun, 2016; 7.
32.
ReitenOK, WilvangMA, MitchellSJ, HuZ, FangEF. Preclinical and clinical evidence of NAD+ precursors in health, disease, and ageing. Mech Ageing Dev, 2021; 199:111567.
33.
NacarelliT, LauL, FukumotoT, et al.NAD+ metabolism governs the proinflammatory senescence-associated secretome. Nat Cell Biol, 2019; 21:397–407.
34.
SøgaardPP, GilJ. NAD+: A metabolic knob fine-tuning inflammation during senescence. Nat Metab, 2019; 1:310–311.
35.
BaumCL, SelhubJ, RosenbergIH. The hydrolysis of nicotinamide adenine nucleotide by brush border membranes of rat intestine. Biochem J, 1982; 204:203–207.
36.
SpectorR, JohansonCE. Review: Vitamin transport and homeostasis in mammalian brain: Focus on Vitamins B and E. J Neurochem, 2007; 103:425–438.
37.
VanniniN, CamposV, GirotraM, et al.The NAD-booster nicotinamide riboside potently stimulates hematopoiesis through increased mitochondrial clearance. Cell Stem Cell, 2019; 24:405–418.e7.
38.
LiuL, SuX, QuinnWJ, et al.Quantitative analysis of NAD synthesis-breakdown fluxes. Cell Metab, 2018; 27:1067–1080.e5.
39.
WuLE, SinclairDA. The elusive NMN transporter is found. Nat Metab, 2019; 1:8–9.
40.
RohE, KimM-S. Hypothalamic NAD+-sirtuin axis: Function and regulation. Biomolecules, 2020; 10:396.
41.
MontagneA, ZhaoZ, ZlokovicBV. Alzheimer's disease: A matter of blood–brain barrier dysfunction?. J Exp Med, 2017; 214:3151–3169.
42.
SchöndorfDC, IvanyukD, BadenP, et al.The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson's disease. Cell Rep, 2018; 23:2976–2988.
43.
GomesAP, PriceNL, LingAJY, et al.Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell, 2013; 155:1624–1638.
44.
MengF, QianM, PengB, et al. Synergy between SIRT1 and SIRT6 helps recognize DNA breaks and potentiates the DNA damage response and repair in humans and mice. eLife 9:e55828.
45.
KanfiY, PeshtiV, GozlanYM, RathausM, GilR, CohenHY. Regulation of SIRT1 protein levels by nutrient availability. FEBS Lett, 2008; 582:2417–2423.
46.
KanfiY, ShalmanR, PeshtiV, et al.Regulation of SIRT6 protein levels by nutrient availability. FEBS Lett, 2008; 582:543–548.
47.
CohenHY. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science, 2004; 305:390–392.
48.
ZhuY, YanY, GiusDR, VassilopoulosA. Metabolic regulation of sirtuins upon fasting and the implication for cancer. Curr Opin Oncol, 2013; 25:630–636.
49.
ZhangN, LiZ, MuW, et al.Calorie restriction-induced SIRT6 activation delays aging by suppressing NF-κB signaling. Cell Cycle, 2016; 15:1009–1018.
50.
RoichmanA, ElhanatiS, AonMA, et al.Restoration of energy homeostasis by SIRT6 extends healthy lifespan. Nat Commun, 2021; 12:3208.
51.
RoichmanA, KanfiY, GlazzR, et al.SIRT6 overexpression improves various aspects of mouse healthspan. J Gerontol A, 2017; 72:603–615.
